More specifically, Yang et al. [85] showed that miR-214 and miR-150 are highly up-regulated in ovarian cancer and act as oncomiRs, inhibiting the expression of PTEN tumour suppressor gene, thus initiating the protein kinase B (ACT) pathway. The gene discussed is PTEN; the disease is ovarian carcinoma.